Global Drugs for HIV Sales Market Report 2021

Global Drugs for HIV Sales Market Report 2021

Table of Contents
1 Drugs for HIV Market Overview
1.1 Drugs for HIV Product Scope
1.2 Drugs for HIV Segment by Type
1.2.1 Global Drugs for HIV Sales by Type (2016 & 2021 & 2027)
1.2.2 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.2.3 Integrase Inhibitors
1.2.4 Combination HIV Medicines
1.2.5 Others
1.3 Drugs for HIV Segment by Application
1.3.1 Global Drugs for HIV Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Drugs for HIV Market Estimates and Forecasts (2016-2027)
1.4.1 Global Drugs for HIV Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Drugs for HIV Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Drugs for HIV Price Trends (2016-2027)
2 Drugs for HIV Estimates and Forecasts by Region
2.1 Global Drugs for HIV Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Drugs for HIV Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Drugs for HIV Sales Market Share by Region (2016-2021)
2.2.2 Global Drugs for HIV Revenue Market Share by Region (2016-2021)
2.3 Global Drugs for HIV Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Drugs for HIV Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Drugs for HIV Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Drugs for HIV Estimates and Projections (2016-2027)
2.4.2 Europe Drugs for HIV Estimates and Projections (2016-2027)
2.4.3 China Drugs for HIV Estimates and Projections (2016-2027)
2.4.4 Japan Drugs for HIV Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Drugs for HIV Estimates and Projections (2016-2027)
2.4.6 India Drugs for HIV Estimates and Projections (2016-2027)
3 Global Drugs for HIV Competition Landscape by Players
3.1 Global Top Drugs for HIV Players by Sales (2016-2021)
3.2 Global Top Drugs for HIV Players by Revenue (2016-2021)
3.3 Global Drugs for HIV Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drugs for HIV as of 2020)
3.4 Global Drugs for HIV Average Price by Company (2016-2021)
3.5 Manufacturers Drugs for HIV Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Drugs for HIV Market Size by Type
4.1 Global Drugs for HIV Historic Market Review by Type (2016-2021)
4.1.1 Global Drugs for HIV Sales Market Share by Type (2016-2021)
4.1.2 Global Drugs for HIV Revenue Market Share by Type (2016-2021)
4.1.3 Global Drugs for HIV Price by Type (2016-2021)
4.2 Global Drugs for HIV Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Drugs for HIV Sales Forecast by Type (2022-2027)
4.2.2 Global Drugs for HIV Revenue Forecast by Type (2022-2027)
4.2.3 Global Drugs for HIV Price Forecast by Type (2022-2027)
5 Global Drugs for HIV Market Size by Application
5.1 Global Drugs for HIV Historic Market Review by Application (2016-2021)
5.1.1 Global Drugs for HIV Sales Market Share by Application (2016-2021)
5.1.2 Global Drugs for HIV Revenue Market Share by Application (2016-2021)
5.1.3 Global Drugs for HIV Price by Application (2016-2021)
5.2 Global Drugs for HIV Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Drugs for HIV Sales Forecast by Application (2022-2027)
5.2.2 Global Drugs for HIV Revenue Forecast by Application (2022-2027)
5.2.3 Global Drugs for HIV Price Forecast by Application (2022-2027)
6 North America Drugs for HIV Market Facts & Figures
6.1 North America Drugs for HIV Sales by Company
6.1.1 North America Drugs for HIV Sales by Company (2016-2021)
6.1.2 North America Drugs for HIV Revenue by Company (2016-2021)
6.2 North America Drugs for HIV Sales Breakdown by Type
6.2.1 North America Drugs for HIV Sales Breakdown by Type (2016-2021)
6.2.2 North America Drugs for HIV Sales Breakdown by Type (2022-2027)
6.3 North America Drugs for HIV Sales Breakdown by Application
6.3.1 North America Drugs for HIV Sales Breakdown by Application (2016-2021)
6.3.2 North America Drugs for HIV Sales Breakdown by Application (2022-2027)
7 Europe Drugs for HIV Market Facts & Figures
7.1 Europe Drugs for HIV Sales by Company
7.1.1 Europe Drugs for HIV Sales by Company (2016-2021)
7.1.2 Europe Drugs for HIV Revenue by Company (2016-2021)
7.2 Europe Drugs for HIV Sales Breakdown by Type
7.2.1 Europe Drugs for HIV Sales Breakdown by Type (2016-2021)
7.2.2 Europe Drugs for HIV Sales Breakdown by Type (2022-2027)
7.3 Europe Drugs for HIV Sales Breakdown by Application
7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)
8 China Drugs for HIV Market Facts & Figures
8.1 China Drugs for HIV Sales by Company
8.1.1 China Drugs for HIV Sales by Company (2016-2021)
8.1.2 China Drugs for HIV Revenue by Company (2016-2021)
8.2 China Drugs for HIV Sales Breakdown by Type
8.2.1 China Drugs for HIV Sales Breakdown by Type (2016-2021)
8.2.2 China Drugs for HIV Sales Breakdown by Type (2022-2027)
8.3 China Drugs for HIV Sales Breakdown by Application
8.3.1 China 242 Sales Breakdown by Application (2016-2021)
8.3.2 China 242 Sales Breakdown by Application (2022-2027)
9 Japan Drugs for HIV Market Facts & Figures
9.1 Japan Drugs for HIV Sales by Company
9.1.1 Japan Drugs for HIV Sales by Company (2016-2021)
9.1.2 Japan Drugs for HIV Revenue by Company (2016-2021)
9.2 Japan Drugs for HIV Sales Breakdown by Type
9.2.1 Japan Drugs for HIV Sales Breakdown by Type (2016-2021)
9.2.2 Japan Drugs for HIV Sales Breakdown by Type (2022-2027)
9.3 Japan Drugs for HIV Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Drugs for HIV Market Facts & Figures
10.1 Southeast Asia Drugs for HIV Sales by Company
10.1.1 Southeast Asia Drugs for HIV Sales by Company (2016-2021)
10.1.2 Southeast Asia Drugs for HIV Revenue by Company (2016-2021)
10.2 Southeast Asia Drugs for HIV Sales Breakdown by Type
10.2.1 Southeast Asia Drugs for HIV Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Drugs for HIV Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Drugs for HIV Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Drugs for HIV Market Facts & Figures
11.1 India Drugs for HIV Sales by Company
11.1.1 India Drugs for HIV Sales by Company (2016-2021)
11.1.2 India Drugs for HIV Revenue by Company (2016-2021)
11.2 India Drugs for HIV Sales Breakdown by Type
11.2.1 India Drugs for HIV Sales Breakdown by Type (2016-2021)
11.2.2 India Drugs for HIV Sales Breakdown by Type (2022-2027)
11.3 India Drugs for HIV Sales Breakdown by Application
11.3.1 India Drugs for HIV Sales Breakdown by Application (2016-2021)
11.3.2 India Drugs for HIV Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Drugs for HIV Business
12.1 ViiV Healthcare
12.1.1 ViiV Healthcare Corporation Information
12.1.2 ViiV Healthcare Business Overview
12.1.3 ViiV Healthcare Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
12.1.4 ViiV Healthcare Drugs for HIV Products Offered
12.1.5 ViiV Healthcare Recent Development
12.2 Gilead Sciences, Inc
12.2.1 Gilead Sciences, Inc Corporation Information
12.2.2 Gilead Sciences, Inc Business Overview
12.2.3 Gilead Sciences, Inc Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Gilead Sciences, Inc Drugs for HIV Products Offered
12.2.5 Gilead Sciences, Inc Recent Development
12.3 Merck Sharp & Dohme Corp
12.3.1 Merck Sharp & Dohme Corp Corporation Information
12.3.2 Merck Sharp & Dohme Corp Business Overview
12.3.3 Merck Sharp & Dohme Corp Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Sharp & Dohme Corp Drugs for HIV Products Offered
12.3.5 Merck Sharp & Dohme Corp Recent Development
12.4 Bristol-Myers Squibb Company
12.4.1 Bristol-Myers Squibb Company Corporation Information
12.4.2 Bristol-Myers Squibb Company Business Overview
12.4.3 Bristol-Myers Squibb Company Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bristol-Myers Squibb Company Drugs for HIV Products Offered
12.4.5 Bristol-Myers Squibb Company Recent Development
12.5 Janssen Pharmaceuticals, Inc.
12.5.1 Janssen Pharmaceuticals, Inc. Corporation Information
12.5.2 Janssen Pharmaceuticals, Inc. Business Overview
12.5.3 Janssen Pharmaceuticals, Inc. Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Janssen Pharmaceuticals, Inc. Drugs for HIV Products Offered
12.5.5 Janssen Pharmaceuticals, Inc. Recent Development
12.6 Theratechnologies Inc.
12.6.1 Theratechnologies Inc. Corporation Information
12.6.2 Theratechnologies Inc. Business Overview
12.6.3 Theratechnologies Inc. Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Theratechnologies Inc. Drugs for HIV Products Offered
12.6.5 Theratechnologies Inc. Recent Development
12.7 Mylan Pharmaceuticals Inc.
12.7.1 Mylan Pharmaceuticals Inc. Corporation Information
12.7.2 Mylan Pharmaceuticals Inc. Business Overview
12.7.3 Mylan Pharmaceuticals Inc. Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Mylan Pharmaceuticals Inc. Drugs for HIV Products Offered
12.7.5 Mylan Pharmaceuticals Inc. Recent Development
12.8 Genentech, Inc.
12.8.1 Genentech, Inc. Corporation Information
12.8.2 Genentech, Inc. Business Overview
12.8.3 Genentech, Inc. Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Genentech, Inc. Drugs for HIV Products Offered
12.8.5 Genentech, Inc. Recent Development
12.9 AbbVie Inc.
12.9.1 AbbVie Inc. Corporation Information
12.9.2 AbbVie Inc. Business Overview
12.9.3 AbbVie Inc. Drugs for HIV Sales, Revenue and Gross Margin (2016-2021)
12.9.4 AbbVie Inc. Drugs for HIV Products Offered
12.9.5 AbbVie Inc. Recent Development
13 Drugs for HIV Manufacturing Cost Analysis
13.1 Drugs for HIV Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Drugs for HIV
13.4 Drugs for HIV Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Drugs for HIV Distributors List
14.3 Drugs for HIV Customers
15 Market Dynamics
15.1 Drugs for HIV Market Trends
15.2 Drugs for HIV Drivers
15.3 Drugs for HIV Market Challenges
15.4 Drugs for HIV Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Drugs for HIV Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Drugs for HIV Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Drugs for HIV Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Drugs for HIV Sales (K Units) by Region (2016-2021)
Table 5. Global Drugs for HIV Sales Market Share by Region (2016-2021)
Table 6. Global Drugs for HIV Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Drugs for HIV Revenue Share by Region (2016-2021)
Table 8. Global Drugs for HIV Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Drugs for HIV Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Drugs for HIV Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Drugs for HIV Revenue Share Forecast by Region (2022-2027)
Table 12. Global Drugs for HIV Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Drugs for HIV Sales Share by Company (2016-2021)
Table 14. Global Drugs for HIV Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Drugs for HIV Revenue Share by Company (2016-2021)
Table 16. Global Drugs for HIV by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for HIV as of 2020)
Table 17. Global Drugs for HIV Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Drugs for HIV Manufacturing Sites and Area Served
Table 19. Manufacturers Drugs for HIV Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Drugs for HIV Sales (K Units) by Type (2016-2021)
Table 22. Global Drugs for HIV Sales Share by Type (2016-2021)
Table 23. Global Drugs for HIV Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Drugs for HIV Price (US$/Unit) by Type (2016-2021)
Table 25. Global Drugs for HIV Sales Share by Type (2022-2027)
Table 26. Global Drugs for HIV Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Drugs for HIV Revenue Share by Type (2022-2027)
Table 28. Global Drugs for HIV Price (US$/Unit) by Type (2022-2027)
Table 29. Global Drugs for HIV Sales (K Units) by Application (2016-2021)
Table 30. Global Drugs for HIV Sales Share by Application (2016-2021)
Table 31. Global Drugs for HIV Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Drugs for HIV Price (US$/Unit) by Application (2016-2021)
Table 33. Global Drugs for HIV Sales (K Units) by Application (2022-2027)
Table 34. Global Drugs for HIV Sales Share by Application (2022-2027)
Table 35. Global Drugs for HIV Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Drugs for HIV Revenue Share by Application (2022-2027)
Table 37. Global Drugs for HIV Price (US$/Unit) by Application (2022-2027)
Table 38. North America Drugs for HIV Sales (K Units) by Company (2016-2021)
Table 39. North America Drugs for HIV Sales Market Share by Company (2016-2021)
Table 40. North America Drugs for HIV Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Drugs for HIV Revenue Market Share by Company (2016-2021)
Table 42. North America Drugs for HIV Sales by Type (2016-2021) & (K Units)
Table 43. North America Drugs for HIV Sales Market Share by Type (2016-2021)
Table 44. North America Drugs for HIV Sales by Type (2022-2027) & (K Units)
Table 45. North America Drugs for HIV Sales Market Share by Type (2022-2027)
Table 46. North America Drugs for HIV Sales by Application (2016-2021) & (K Units)
Table 47. North America Drugs for HIV Sales Market Share by Application (2016-2021)
Table 48. North America Drugs for HIV Sales by Application (2022-2027) & (K Units)
Table 49. North America Drugs for HIV Sales Market Share by Application (2022-2027)
Table 50. Europe Drugs for HIV Sales (K Units) by Company (2016-2021)
Table 51. Europe Drugs for HIV Sales Market Share by Company (2016-2021)
Table 52. Europe Drugs for HIV Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Drugs for HIV Revenue Market Share by Company (2016-2021)
Table 54. Europe Drugs for HIV Sales by Type (2016-2021) & (K Units)
Table 55. Europe Drugs for HIV Sales Market Share by Type (2016-2021)
Table 56. Europe Drugs for HIV Sales by Type (2022-2027) & (K Units)
Table 57. Europe Drugs for HIV Sales Market Share by Type (2022-2027)
Table 58. Europe Drugs for HIV Sales by Application (2016-2021) & (K Units)
Table 59. Europe Drugs for HIV Sales Market Share by Application (2016-2021)
Table 60. Europe Drugs for HIV Sales by Application (2022-2027) & (K Units)
Table 61. Europe Drugs for HIV Sales Market Share by Application (2022-2027)
Table 62. China Drugs for HIV Sales (K Units) by Company (2016-2021)
Table 63. China Drugs for HIV Sales Market Share by Company (2016-2021)
Table 64. China Drugs for HIV Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Drugs for HIV Revenue Market Share by Company (2016-2021)
Table 66. China Drugs for HIV Sales by Type (2016-2021) & (K Units)
Table 67. China Drugs for HIV Sales Market Share by Type (2016-2021)
Table 68. China Drugs for HIV Sales by Type (2022-2027) & (K Units)
Table 69. China Drugs for HIV Sales Market Share by Type (2022-2027)
Table 70. China Drugs for HIV Sales by Application (2016-2021) & (K Units)
Table 71. China Drugs for HIV Sales Market Share by Application (2016-2021)
Table 72. China Drugs for HIV Sales by Application (2022-2027) & (K Units)
Table 73. China Drugs for HIV Sales Market Share by Application (2022-2027)
Table 74. Japan Drugs for HIV Sales (K Units) by Company (2016-2021)
Table 75. Japan Drugs for HIV Sales Market Share by Company (2016-2021)
Table 76. Japan Drugs for HIV Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Drugs for HIV Revenue Market Share by Company (2016-2021)
Table 78. Japan Drugs for HIV Sales by Type (2016-2021) & (K Units)
Table 79. Japan Drugs for HIV Sales Market Share by Type (2016-2021)
Table 80. Japan Drugs for HIV Sales by Type (2022-2027) & (K Units)
Table 81. Japan Drugs for HIV Sales Market Share by Type (2022-2027)
Table 82. Japan Drugs for HIV Sales by Application (2016-2021) & (K Units)
Table 83. Japan Drugs for HIV Sales Market Share by Application (2016-2021)
Table 84. Japan Drugs for HIV Sales by Application (2022-2027) & (K Units)
Table 85. Japan Drugs for HIV Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Drugs for HIV Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Drugs for HIV Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Drugs for HIV Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Drugs for HIV Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Drugs for HIV Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Drugs for HIV Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Drugs for HIV Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Drugs for HIV Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Drugs for HIV Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Drugs for HIV Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Drugs for HIV Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Drugs for HIV Sales Market Share by Application (2022-2027)
Table 98. India Drugs for HIV Sales (K Units) by Company (2016-2021)
Table 99. India Drugs for HIV Sales Market Share by Company (2016-2021)
Table 100. India Drugs for HIV Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Drugs for HIV Revenue Market Share by Company (2016-2021)
Table 102. India Drugs for HIV Sales by Type (2016-2021) & (K Units)
Table 103. India Drugs for HIV Sales Market Share by Type (2016-2021)
Table 104. India Drugs for HIV Sales by Type (2022-2027) & (K Units)
Table 105. India Drugs for HIV Sales Market Share by Type (2022-2027)
Table 106. India Drugs for HIV Sales by Application (2016-2021) & (K Units)
Table 107. India Drugs for HIV Sales Market Share by Application (2016-2021)
Table 108. India Drugs for HIV Sales by Application (2022-2027) & (K Units)
Table 109. India Drugs for HIV Sales Market Share by Application (2022-2027)
Table 110. ViiV Healthcare Corporation Information
Table 111. ViiV Healthcare Description and Business Overview
Table 112. ViiV Healthcare Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. ViiV Healthcare Drugs for HIV Product
Table 114. ViiV Healthcare Recent Development
Table 115. Gilead Sciences, Inc Corporation Information
Table 116. Gilead Sciences, Inc Description and Business Overview
Table 117. Gilead Sciences, Inc Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Gilead Sciences, Inc Drugs for HIV Product
Table 119. Gilead Sciences, Inc Recent Development
Table 120. Merck Sharp & Dohme Corp Corporation Information
Table 121. Merck Sharp & Dohme Corp Description and Business Overview
Table 122. Merck Sharp & Dohme Corp Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Merck Sharp & Dohme Corp Drugs for HIV Product
Table 124. Merck Sharp & Dohme Corp Recent Development
Table 125. Bristol-Myers Squibb Company Corporation Information
Table 126. Bristol-Myers Squibb Company Description and Business Overview
Table 127. Bristol-Myers Squibb Company Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Bristol-Myers Squibb Company Drugs for HIV Product
Table 129. Bristol-Myers Squibb Company Recent Development
Table 130. Janssen Pharmaceuticals, Inc. Corporation Information
Table 131. Janssen Pharmaceuticals, Inc. Description and Business Overview
Table 132. Janssen Pharmaceuticals, Inc. Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Janssen Pharmaceuticals, Inc. Drugs for HIV Product
Table 134. Janssen Pharmaceuticals, Inc. Recent Development
Table 135. Theratechnologies Inc. Corporation Information
Table 136. Theratechnologies Inc. Description and Business Overview
Table 137. Theratechnologies Inc. Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Theratechnologies Inc. Drugs for HIV Product
Table 139. Theratechnologies Inc. Recent Development
Table 140. Mylan Pharmaceuticals Inc. Corporation Information
Table 141. Mylan Pharmaceuticals Inc. Description and Business Overview
Table 142. Mylan Pharmaceuticals Inc. Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Mylan Pharmaceuticals Inc. Drugs for HIV Product
Table 144. Mylan Pharmaceuticals Inc. Recent Development
Table 145. Genentech, Inc. Corporation Information
Table 146. Genentech, Inc. Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Genentech, Inc. Description and Business Overview
Table 148. Genentech, Inc. Drugs for HIV Product
Table 149. Genentech, Inc. Recent Development
Table 150. AbbVie Inc. Corporation Information
Table 151. AbbVie Inc. Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. AbbVie Inc. Description and Business Overview
Table 153. AbbVie Inc. Drugs for HIV Product
Table 154. AbbVie Inc. Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Drugs for HIV Distributors List
Table 158. Drugs for HIV Customers List
Table 159. Drugs for HIV Market Trends
Table 160. Drugs for HIV Market Drivers
Table 161. Drugs for HIV Market Challenges
Table 162. Drugs for HIV Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for HIV Product Picture
Figure 2. Global Drugs for HIV Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Drugs for HIV Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Online Pharmacies Examples
Figure 9. Others Examples
Figure 10. Global Drugs for HIV Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Drugs for HIV Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Drugs for HIV Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Drugs for HIV Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 14. Global Drugs for HIV Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Drugs for HIV Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Drugs for HIV Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Drugs for HIV Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Drugs for HIV Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Drugs for HIV Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Drugs for HIV Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Drugs for HIV Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Drugs for HIV Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Drugs for HIV Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Drugs for HIV Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Drugs for HIV Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Drugs for HIV Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Drugs for HIV Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Drugs for HIV Players Market Share by Revenue in Drugs for HIV: 2016 & 2020
Figure 29. Drugs for HIV Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Drugs for HIV Revenue Share by Type (2016-2021)
Figure 31. Global Drugs for HIV Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Drugs for HIV Revenue Share by Application (2016-2021)
Figure 33. Global Drugs for HIV Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Drugs for HIV Sales Market Share by Type in 2020
Figure 35. North America Drugs for HIV Sales Market Share by Application in 2020
Figure 36. Europe Drugs for HIV Sales Market Share by Type in 2020
Figure 37. Europe Drugs for HIV Sales Market Share by Application in 2020
Figure 38. China Drugs for HIV Sales Market Share by Type in 2020
Figure 39. China Drugs for HIV Sales Market Share by Application in 2020
Figure 40. Japan Drugs for HIV Sales Market Share by Type in 2020
Figure 41. Japan Drugs for HIV Sales Market Share by Application in 2020
Figure 42. Southeast Asia Drugs for HIV Sales Market Share by Type in 2020
Figure 43. Southeast Asia Drugs for HIV Sales Market Share by Application in 2020
Figure 44. India Drugs for HIV Sales Market Share by Type in 2020
Figure 45. India Drugs for HIV Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Drugs for HIV
Figure 48. Manufacturing Process Analysis of Drugs for HIV
Figure 49. Drugs for HIV Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs